The University of Houston has received a grant from the Baker Hughes Foundation. Photo courtesy of University of Houston

A Houston school is cashing in a major gift from a local energy company in order to support the industry's future workforce, research, and more.

The University of Houston Energy Transition Institute received a $100,000 grant from the Baker Hughes Foundation last week, which will work towards the ETI’s goals to support workforce development programs, and environmental justice research.

The program addresses the impact of energy transition solutions in geographical areas most-affected by environmental impacts.

“We are proud to support the University of Houston in its environmental justice research and workforce development programs; at Baker Hughes, we strive to take energy forward, and are committed to a fair and just energy transition,” says Chief Sustainability Officer Allyson Book in a news release. “Novel educational approaches centered around social, climate and environmental justice are crucial to creating a sustainable future for generations to come.”

The grant aims to help ETI in analyzing environmental footprints of energy use processes, energy use processes, impact on health, and emissions, as well as support the university’s Energy Scholars Program, which focuses on research programs on carbon management, hydrogen, and circular plastics for undergraduate students.The donation also supports Baker Hughes’ work with the United Nations’ Sustainable Development Goals (SDGs) that work to ensure “inclusive and equitable quality education for all.”

“We look forward to working with the Baker Hughes Foundation to address grand challenges in energy and chemicals and create a sustainable and equitable future for all,” says Ramanan Krishnamoorti, vice president of energy and innovation at UH.

ETI launched a year ago through a $10 million grant from Shell USA Inc. and Shell Global Solutions (US) Inc., and is led by Joe Powell, who opted to take the helm of the program over retiring, telling EnergyCapital that it was an opportunity he couldn't pass up.

UH has announced a central campus innovation hub that will house UH's programs for STEM, social sciences, business and arts. Slated to open in 2025, the 70,000 square foot hub will house a makerspace, the Cyvia and Melvyn Wolff Center for Entrepreneurship, the Energy Transition Institute, innovation programs, and Presidential Frontier Faculty labs and offices.

“The University of Houston aims to transform lives and communities through education, research, innovation and service in a real-world setting," Krishnamoorti says in a news release. “I am confident that working together we will make a greater impact.”

------

This article originally ran on EnergyCapital.

This week's roundup of Houston innovators includes Richard Seline of the Resilience Innovation Hub, Joy Jones of Code Wiz, and Joseph Powell of the University of Houston. Photos courtesy

3 Houston innovators to know this week

who's who

Editor's note: In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from energy transition to resiliency — recently making headlines in Houston innovation.

Richard Seline, co-founder of the Resilience Innovation Hub

Richard Seline joins the Houston Innovators Podcast to explain what all Houston has accomplished within resilience innovation — as well as what's next for the city. Photo courtesy of Richard Seline

For Richard Seline, a major advocate for resilience innovation across Houston and beyond, 2022 was a year of recognizing new technologies and processes — as well as threats — to resiliency.

However, 2023 is the year to implement, he says on this week's episode of the Houston Innovators Podcast.

"What really happened in 2022 is the recognition that there are enough technologies, equipment, and data science tools that if you were to deploy all of that more efficiently and effectively, you're going to get a one-to-six better cost benefit. It's kind of a no-brainer," says Seline, co-founder of the Resilience Innovation Hub, a national organization headquartered in Houston. Read more.

Joy Jones, owner of Code Wiz Oak Forest

Joy Jones is opening her Oak Forest location of Code Wiz later this month. Screenshot via Code Wiz

A Houstonian has switched up her career to focus on inspiring and equipping children STEM-focused skills.

Joy Jones, who has worked for a decade in the corporate world, is starting the new year with a new career — this one focused on her passion of providing more STEM programming access to students. In 2021, she came across Code Wiz, a coding school franchise based in Massachusetts with 19 locations across the country, and met with Ruth Agbaji, CEO and "nerd-in-chief" of the company.

“Talking with Ruth and hearing the story of her mission to touch 1 million kids through Code Wiz, I found exactly what I’ve been looking for, a mission that aligned with mine,” says Jones, in a news release. Read more.

Joseph Powell, director of the University of Houston Energy Transition Institute

Former Shell Chief Scientist Joseph Powell has joined UH to lead its new Energy Transition Institute. Photo via uh.edu

The University of Houston has announced the first leader of its Shell-backed Energy Transition Institute.

Joseph Powell has been named the founding director of the institute, which was founded following a $10 million donation from Shell in spring of last year. Powell is the former chief scientist for Shell and member of the National Academy of Engineering, according to a news release from UH.

“What excites me about my new role is the opportunity to work with students, faculty and industry to make a difference on problems that truly matter," Powell says in the release. "Who could pass that up? Imagine the difficulties that arise when you don’t have access to energy. Read more.

Former Shell Chief Scientist Joseph Powell has joined UH to lead its new Energy Transition Institute. Photo via uh.edu

University of Houston names new leader to Shell-supported energy transition initiative

new hire

The University of Houston has announced the first leader of its Shell-backed Energy Transition Institute.

Joseph Powell has been named the founding director of the institute, which was founded following a $10 million donation from Shell in spring of last year. Powell is the former chief scientist for Shell and member of the National Academy of Engineering, according to a news release from UH.

“What excites me about my new role is the opportunity to work with students, faculty and industry to make a difference on problems that truly matter," Powell says in the release. "Who could pass that up? Imagine the difficulties that arise when you don’t have access to energy.

“At this point in time, the global transformation to energy abundance is not complete, so we must grow the energy system while reducing its impact on climate and the environment, and also develop circular systems to recycle materials and reduce waste," he continues. "That’s a tall order, but a necessity to bring clean energy and sustainable chemicals into play globally and develop solutions that improve the quality of life for all.”

The appointment was funded by a matching grant from the Governor’s University Research Initiative, a program that was created in 2015 to help Texas's public universities recruit the top researchers. In addition to his role at the institute, Powell will also serve as a faculty member in the Department of Chemical & Biomolecular Engineering at the UH Cullen College of Engineering.

“Dr. Powell brings extensive experience, insight and passion to the position. I anticipate the institute growing under his leadership to further strengthen UH’s position as the Energy University," says Ramanan Krishnamoorti, vice president for energy and innovation at UH, in the release. "We are grateful Governor Abbott prioritizes funding to bring recognized researchers to Texas through GURI and believe Dr. Powell will play a pivotal role in finding solutions to critical local and global challenges around the energy transition."

Powell's name is associated with over 125 patent applications, with more than 60 granted. He has 36 years of chemical engineering experience and has led research and development programs in new chemical processes, biofuels and enhanced oil recovery.

The new institute — through its faculty and industry partnerships — is geared at education and research into the future of affordable and cleaner energy, including hydrogen, carbon management and circular plastics.

“We must be the trusted voice for stakeholders and the community that is objective and knowledgeable, where industry comes to present ideas and challenges, where faculty come with their research interests and expertise to partner and achieve more together, and where students are transformed into the energy workforce and leaders of tomorrow," he says in the release.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.